Predicting the safety and efficacy of buffer therapy to raise tumour pHe: an integrative modelling study

por Martin, N K, Robey, I F, Gaffney, E A, Gillies, R J, Gatenby, R A, Maini, P K
Publicado 2012

New treatments for hepatitis C virus (HCV): scope for preventing liver disease and HCV transmission in England

por Harris, R. J., Martin, N. K., Rand, E., Mandal, S., Mutimer, D., Vickerman, P., Ramsay, M. E., De Angelis, D., Hickman, M., Harris, H.E.
Publicado 2016

HCV treatment rates and sustained viral response among people who inject drugs in seven UK sites: real world results and modelling of treatment impact

por Martin, N K, Foster, G R, Vilar, J, Ryder, S, E Cramp, M, Gordon, F, Dillon, J F, Craine, N, Busse, H, Clements, A, Hutchinson, S J, Ustianowski, A, Ramsay, M, Goldberg, D J, Irving, W, Hope, V, De Angelis, D, Lyons, M, Vickerman, P, Hickman, M
Publicado 2015